Hepatology 48, 12921301
[1] [2] Gallbladder-related events, including cholelithiasis, have been observed in early trial data, consistent with class-related signals seen with other GLP-1-based weight-loss therapies
Cardiovascular-Kidney-Metabolic (CKM) Syndrome , as defined by the AHA, is a systemic disorder characterized by pathophysiological interactions among metabolic risk factors (such as obesity, insulin resistance, dyslipidemia, and hypertension), chronic kidney disease (CKD), and the cardiovascular system, leading to multiorgan dysfunction and a high rate of adverse cardiovascular outcomes [145]
Common Mistakes to Avoid: Never double dose if you miss one
Food Industry: It serves as a dietary supplement in food products, enhancing nutritional value and supporting overall health, particularly in protein-rich foods aimed at athletes and fitness enthusiasts
Stimulation of Lipolysis (The Push): It upregulates Beta-3 Adrenergic Receptors (3-AR) on fat cells, enhancing the sensitivity to endogenous fat-burning signals
